Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05167409
Title A Study of ALX148 With Cetuximab and Pembrolizumab for Refractory Microsatellite Stable Metastatic Colorectal Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Criterium, Inc.
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Arizona Cancer Center Recruiting Tucson Arizona 85724 United States Details
University of Colorado Cancer Center Recruiting Aurora Colorado 80045 United States Details
Rutgers Cancer insititute Recruiting New Brunswick New Jersey 08903 United States Details
Perlmutter Cancer Center Not yet recruiting New York New York 10016 United States Details
Inova Schar Cancer Institute Not yet recruiting Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from for the field